Finding 963092 (2023-004)

Significant Deficiency
Requirement
E
Questioned Costs
$1
Year
2023
Accepted
2024-03-27
Audit: 298971
Organization: Cabrini University (PA)

AI Summary

  • Core Issue: A student received a subsidized loan exceeding the maximum allowed amount due to improper fund allocation.
  • Impacted Requirements: The finding violates 34 CFR 685.203(a), which sets limits on loan amounts based on dependency status and financial need.
  • Recommended Follow-Up: The University should review and improve its procedures for allocating Title IV funds to ensure compliance with federal regulations.

Finding Text

Federal Agency: U.S. Department of Education Federal Program Title: Student Financial Assistance Cluster Federal Assistance Listing Number: 84.268 Award Period: 7/1/2022 – 6/30/2023 Type of Finding: Significant Deficiency in Internal Control over Compliance, Other Matters Criteria or Specific Requirement: The Code of Federal Regulations, 34 CFR 685.203(a) outline the maximum subsidized loan amounts for students based on their dependency status, year of education, and other factors. Condition: During our testing, we noted 1 student out of 35 where the subsidized direct loan awarded was over the maximum eligible amount. Questioned Costs: $2,275 Context: During our testing, it was noted that 1 student's Title IV was not reallocated properly based on their EFC and outside scholarships they received, therefore, they were over awarded subsidized loans by $2,275. Cause: The University did not reallocate Title IV funds properly based on need and other estimated financial assistance. Effect: The student was not eligible for the specific awarded amount. Repeat Finding: No. Recommendation: We recommend the University evaluate its procedures and a policy around packaging Title IV based on need. Views of Responsible Officials: Management agrees with the finding.

Categories

Questioned Costs Student Financial Aid Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties Significant Deficiency

Other Findings in this Audit

  • 386637 2023-001
    Significant Deficiency
  • 386638 2023-001
    Significant Deficiency
  • 386639 2023-001
    Significant Deficiency
  • 386640 2023-001
    Significant Deficiency
  • 386641 2023-001
    Significant Deficiency
  • 386642 2023-001
    Significant Deficiency
  • 386643 2023-002
    Significant Deficiency
  • 386644 2023-003
    Significant Deficiency Repeat
  • 386645 2023-003
    Significant Deficiency Repeat
  • 386646 2023-003
    Significant Deficiency Repeat
  • 386647 2023-003
    Significant Deficiency Repeat
  • 386648 2023-003
    Significant Deficiency Repeat
  • 386649 2023-003
    Significant Deficiency Repeat
  • 386650 2023-004
    Significant Deficiency
  • 386651 2023-005
    Significant Deficiency
  • 386652 2023-005
    Significant Deficiency
  • 386653 2023-006
    Significant Deficiency
  • 386654 2023-006
    Significant Deficiency
  • 386655 2023-006
    Significant Deficiency
  • 386656 2023-006
    Significant Deficiency
  • 386657 2023-006
    Significant Deficiency
  • 386658 2023-006
    Significant Deficiency
  • 386659 2023-007
    Significant Deficiency Repeat
  • 386660 2023-007
    Significant Deficiency Repeat
  • 963079 2023-001
    Significant Deficiency
  • 963080 2023-001
    Significant Deficiency
  • 963081 2023-001
    Significant Deficiency
  • 963082 2023-001
    Significant Deficiency
  • 963083 2023-001
    Significant Deficiency
  • 963084 2023-001
    Significant Deficiency
  • 963085 2023-002
    Significant Deficiency
  • 963086 2023-003
    Significant Deficiency Repeat
  • 963087 2023-003
    Significant Deficiency Repeat
  • 963088 2023-003
    Significant Deficiency Repeat
  • 963089 2023-003
    Significant Deficiency Repeat
  • 963090 2023-003
    Significant Deficiency Repeat
  • 963091 2023-003
    Significant Deficiency Repeat
  • 963093 2023-005
    Significant Deficiency
  • 963094 2023-005
    Significant Deficiency
  • 963095 2023-006
    Significant Deficiency
  • 963096 2023-006
    Significant Deficiency
  • 963097 2023-006
    Significant Deficiency
  • 963098 2023-006
    Significant Deficiency
  • 963099 2023-006
    Significant Deficiency
  • 963100 2023-006
    Significant Deficiency
  • 963101 2023-007
    Significant Deficiency Repeat
  • 963102 2023-007
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
84.268 Federal Direct Student Loans $9.79M
84.063 Federal Pell Grant Program $2.23M
84.038 Federal Perkins Loan Program $516,627
84.365 English Language Acquisition State Grants $508,661
84.007 Federal Supplemental Educational Opportunity Grants $184,175
84.033 Federal Work-Study Program $84,132
16.525 Grants to Reduce Domestic Violence, Dating Violence, Sexual Assault, and Stalking on Campus $77,328
84.021 Overseas Programs - Group Projects Abroad $74,106
45.149 Promotion of the Humanities_division of Preservation and Access $42,379
84.334 Gaining Early Awareness and Readiness for Undergraduate Programs $24,845
84.016 Undergraduate International Studies and Foreign Language Programs $16,841
84.379 Teacher Education Assistance for College and Higher Education Grants (teach Grants) $10,845